Relmada Therapeutics Announces $6.9 Million Private Placement

By WebmasterOctober 5, 2017November 1st, 2024No Comments

Relmada Therapeutics Announces $6.9 Million Private Placement

Previous PostIntezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Next PostMelior Pharmaceuticals Initiates Phase 2b Study with MLR-1023 for Type 2 Diabetes